Mineralys Therapeutics, Inc.
MLYSCIK 0001933414 · Every Form 4 filed by insiders at this issuer.
Filings
2
Latest Feb 14, 2024
Unique insiders
6
Showing
2 of 2
Page 1
Top insiders
Most active reporters at Mineralys Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| AKKARAJU SRINIVAS | Director10% Owner | 1 |
| Kolchinsky Peter | Director | 1 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 1 |
| RA Capital Healthcare Fund LP | Director | 1 |
| RA Capital Nexus Fund III, L.P. | Director | 1 |
| Shah Rajeev M. | Director | 1 |
All filings
2 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Feb 14, 2024 | RA CAPITAL MANAGEMENT, L.P. Director | A | 1,672,508 | $13.50 | $22,578,858 | |
| Feb 14, 2024 | AKKARAJU SRINIVAS Director · 10% Owner | A | 555,555 | $13.50 | $7,499,993 |
Showing 1–2 of 2
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.